Oramed Pharmaceuticals (ORMP) Q1 2026 Earnings

Screener

Reported May 19, 2026 · After market close

EPS-$0.16

Next report

Nov 12, 2026 (in 2 months)

EPS estimate$0.43

Versus estimates

Revenue

Diluted EPS

Q2 2026-$0.09Miss by $0.52

Q1 2026-$0.16

Q4 2025-$0.06Beat by $0.02 Q3 2025$1.13Beat by $1.17 Q2 2025-$0.05Miss by $0.01 Q1 2025-$0.19Miss by $0.16

FAQ

When did Oramed Pharmaceuticals report Q1 2026 earnings?: Oramed Pharmaceuticals (ORMP) reported Q1 2026 earnings on May 19, 2026 after market close.
What were Oramed Pharmaceuticals's Q1 2026 revenue and EPS?: Oramed Pharmaceuticals reported eps of $-0.16 for Q1 2026.
How did Oramed Pharmaceuticals's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 15.8% from $-0.19.
Where can I find Oramed Pharmaceuticals's Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001213900-26-059112) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Oramed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk